Chen X. Yao

38 Xueyuan Road
Haidian, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol.

Chiglitazar in combination with anti-inflammatory and hepatoprotective therapy for the treatment of MASH associated with T2DM: a prospective, multicentre, randomised, double-blind, placebo-controlled study protocol.

Journal: BMJ open

Published: May 18, 2026

The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.

The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.

Journal: BMJ (Clinical research ed.)

Published: January 15, 2025

A Core Outcome Set for Clinical Trials on Post COVID-19 Condition: "What," "When," and "How" to Measure.

A Core Outcome Set for Clinical Trials on Post COVID-19 Condition: "What," "When," and "How" to Measure.

Journal: Journal of evidence-based medicine

Published: December 24, 2024

Pathogenic profiles and lower respiratory tract microbiota in severe pneumonia patients using metagenomic next-generation sequencing.

Pathogenic profiles and lower respiratory tract microbiota in severe pneumonia patients using metagenomic next-generation sequencing.

Journal: Advanced biotechnology

Published: November 01, 2024

Bayesian Proactive Dynamic Borrowing Utilizing Propensity Score Overlap for a Hybrid Control Arm and the Impacts of Various Biases: A Simulation Study.

Bayesian Proactive Dynamic Borrowing Utilizing Propensity Score Overlap for a Hybrid Control Arm and the Impacts of Various Biases: A Simulation Study.

Journal: Journal of evidence-based medicine

Published: September 29, 2024

Distribution and extended triage of high-risk human papillomavirus genotyping based on vaginal self-sampling.

Distribution and extended triage of high-risk human papillomavirus genotyping based on vaginal self-sampling.

Journal: BMJ public health

Published: July 16, 2024

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial.

Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial.

Journal: BMC medicine

Published: June 16, 2024

Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial.

Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial.

Journal: JAMA internal medicine

Published: June 03, 2024

Enhancing the interoperability and transparency of real-world data extraction in clinical research: evaluating the feasibility and impact of a ChatGLM implementation in Chinese hospital settings.

Enhancing the interoperability and transparency of real-world data extraction in clinical research: evaluating the feasibility and impact of a ChatGLM implementation in Chinese hospital settings.

Journal: European heart journal. Digital health

Published: May 14, 2024

Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial : Author detials.

Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial : Author detials.

Journal: Scientific reports

Published: April 28, 2024

Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.

Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.

Journal: EClinicalMedicine

Published: February 18, 2024

Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial.

Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial.

Journal: Trials

Published: September 22, 2023

Showing 1-12 of 71

Last Updated: 09/26/2026